optimist outlook larg bake downgrad
downgrad stock perform rate previou rate
outperform pt withdrawn street expect
view larg bake beat better consensu
outlook posit outcom interim readout peripher diabet
neuropathi pdn studi posit omnia launch current equiti valu
equat newli introduc estim y/i growth
comparison aggreg med-tech univers current trade forward price/
sale prospect growth believ prudent step asid
fundament catalyst emerg warrant even higher multipl stock
consensu revenu estim estim
guidanc impli year/year growth infer
manag commentari sale forc disrupt behind us
strateg realign bear fruit nice print
posit pdn interim readout due nan well telegraph
manag seem reflect stock howev note
pdn patient control endocrinologist henc referr dynam
challeng usual last-resort therapi full readout
late reimburs exist current approv
late earliest
ou number roughli flattish seven quarter ou
field check pick fundament dynam chang recent
us launch omnia critic outlook unclear us
stack vs wavewrit garner posit review
consensu impli y/i growth slightli tweak
estim bring line consensu ou
us growth market share current pariti abbott/medtron
aggreg market grow henc higher growth
share gain could necessit higher opex
subscrib theori ascrib higher higher multipl keep
market behavior focu fundament view
outlook significantli better consensu see current
henc downgrad
year price histori nevro
manufactur market spinal
analyst certif import disclosur see disclosur
omnia launch pariti wavewrit
fundament believ ceo keith grossman steer
ship current cours hyper-growth year
behind street expect remain high howev
omnia modular waveform devic present
pdn trial result
omnia present competit advantag current
factor analysi
reimburs chang posit
omnia launch go well plan
reimburs get chang downsid
modular waveform design featur get ip
statement oper
good sold
sg
stock price compani mention report
